Validation of Myocardial Perfusion Imaging (CameraCZT)
Coronary Artery Disease
About this trial
This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring coronary artery disease, cardiac nuclear medicine, myocardial perfusion imaging, invasive coronary angiography
Eligibility Criteria
Inclusion Criteria:
- Stable angina
- Cadmium-zinc-telluride gamma camera SPECT with dual isotope imaging
- Coronarography
Exclusion Criteria:
- Pregnant woman
- Patient with terminal illness,
- Terminal Renal failure
- Allergy to iodine
Sites / Locations
- University Hospital
Arms of the Study
Arm 1
Other
coronary angiography-FFR-CZT
Patients who were referred to our cardiology department for stress-rest CZT SPECT for known or suspected CAD and submitted for a clinical reason to invasive coronary angiography within 2 month of the SPECT studies. for these patients, A 6 French arterial sheath was introduced into the radial artery. After administration of 5000 U heparin, the guiding catheter was advanced into the coronary ostium. Intracoronary nitroglycerin 0.2 mg was administered, and reference images were made. Significant CAD was defined as presentation of a stenosis ≥70 % in the three-epicardial vessels and ≥ 50 % in left main coronary disease. If necessary (at the discretion of the practitioner) the pressure wire was advanced across the stenosis, and Fractional flow reserve (FFR) was measured.